Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Raises $9 Million in Series A Round

NEW YORK, Oct. 13 (GenomeWeb News) - Metabolon has raised $9 million in a Series A round of financing, the Research Triangle Park, NC-based firm announced today.

 

Metabolon is developing a metabolomics platform for the discovery and development of drugs and early diagnosis of disease states. The firm was founded in 2001 and is headed by John Ryalis, the former CEO of Paradigm Genetics.

 

Metabolon raised $4 million in a first round of venture capital funding in 2003.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.